What is Palynziq, and what is it used for?
Palynziq (generic name: pegvaliase) is an enzyme replacement therapy designed to lower blood levels of phenylalanine. It is used to treat adults with phenylketonuria (PKU), specifically when the condition is not well controlled despite other treatments (including dietary management), or when patients are unable to meet targets with standard therapy. [1]
How does Palynziq work?
Palynziq contains pegvaliase, a modified enzyme that breaks down phenylalanine into other substances. By reducing phenylalanine in the blood, it helps limit the effects of phenylalanine accumulation that occur in PKU. [1]
Who can take it?
Palynziq is indicated for adults with PKU who have inadequate blood phenylalanine control with existing therapy. It is not presented here as a treatment for children or for all PKU patients. [1]
Is Palynziq the same as other PKU medicines?
Palynziq is different from dietary treatments and from other PKU approaches that focus on restricting phenylalanine intake or improving its metabolism. It is an injected therapy that directly targets circulating phenylalanine by enzymatic breakdown. [1]
What kinds of side effects are people most concerned about?
A key practical concern with Palynziq is that it can cause allergic reactions, including serious hypersensitivity events in some patients, which is why use typically involves careful monitoring and attention to reaction symptoms. [1]
Sources
- https://www.palynziq.com/